Acetylsalicylic acid Completed Phase 2 Trials for Cerebral Hemorrhage / Atrial Fibrillation (AF) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02998905NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICH